Brave Asset Management Inc Fulgent Genetics, Inc. Transaction History

Brave Asset Management Inc

  • $410 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 15, 2022
SELL
$47.98 - $62.75 $153,536 - $200,800
-3,200 Closed
0 $0
Q1 2022

Apr 22, 2022
BUY
$49.85 - $96.11 $159,520 - $307,552
3,200 New
3,200 $200,000
Q3 2021

Nov 02, 2021
SELL
$74.87 - $110.87 $187,175 - $277,175
-2,500 Closed
0 $0
Q2 2021

Jul 27, 2021
BUY
$66.8 - $100.45 $167,000 - $251,125
2,500 New
2,500 $231,000

Others Institutions Holding FLGT

# of Institutions
201
Shares Held
16.1M
Call Options Held
2.04M
Put Options Held
14K
View Full List

About Fulgent Genetics, Inc.

FLGT Quotes by TradingView
  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $609M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Brave Asset Management Inc Portfolio

Follow Brave Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brave Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brave Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email